Clostridioides difficile and Staphylococcus aureus are two well-known pathogens both
causing hospital-and community-acquired infections. However, their intestinal coexistence …

Objective To investigate the clinical features of Clostridium difficile infection (CDI) in
hospitalized patients with inflammatory bowel disease (IBD) and to analyze the impact of …

Background Patients with inflammatory bowel disease (IBD) are at greater risk for
Clostridioides difficile infection (CDI). There remain controversial issues about the …

Background Although Clostridium difficile may be associated with exacerbations in
inflammatory bowel diseases (IBD), prospective studies identifying the role of C. difficile in …

Recent changes in the epidemiology of Clostridium difficile infection (CDI) include the
identification of patients with inflammatory bowel disease (IBD) as a group at risk in …

Abstract Objectives Clostridioides (previously Clostridium) difficile is a major growing cause
of nosocomial diarrhoea known as C. difficile infection (CDI). This study investigated the …

Background Clostridioides (Clostridium) difficile infection (CDI) is an important health care-
associated infection with variable incidence and prevalence across the globe. There are …

Aims Patients with inflammatory bowel disease (IBD) are at increased risk for Clostridioides
difficile infection, although clinically important infections can be difficult to recognise. C …

Clostridium difficile is a frequently identified cause of nosocomial gastrointestinal disease. It
has been proved to be a causative agent in antibiotic-associated diarrhea, antibiotic …

Aim In this study, the prevalence of C. difficile, from patients with gastrointestinal complaints
and its association with other enteropathogen microbes were investigated. Background …